| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| US25576300P | 2000-12-15 | 2000-12-15 | |
| US60/255,763 | 2000-12-15 | ||
| US27428401P | 2001-03-08 | 2001-03-08 | |
| US60/274,284 | 2001-03-08 | ||
| PCT/US2001/044231WO2002048148A2 (en) | 2000-12-15 | 2001-11-26 | Pyrazolopyridine derivatives | 
| Publication Number | Publication Date | 
|---|---|
| AU2002239348A1true AU2002239348A1 (en) | 2002-06-24 | 
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| AU2002239348AAbandonedAU2002239348A1 (en) | 2000-12-15 | 2001-11-26 | Pyrazolopyridine derivatives | 
| Country | Link | 
|---|---|
| US (2) | US7163940B2 (en) | 
| EP (1) | EP1377573B1 (en) | 
| JP (1) | JP2004515550A (en) | 
| AT (1) | ATE300541T1 (en) | 
| AU (1) | AU2002239348A1 (en) | 
| DE (1) | DE60112330T2 (en) | 
| ES (1) | ES2243579T3 (en) | 
| WO (1) | WO2002048148A2 (en) | 
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| PE20020506A1 (en) | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | PIRAZOLE DERIVATIVES FUSED AS PROTEIN KINASE INHIBITORS | 
| AU2002239348A1 (en) | 2000-12-15 | 2002-06-24 | Glaxo Group Limited | Pyrazolopyridine derivatives | 
| ATE301653T1 (en) | 2000-12-15 | 2005-08-15 | Glaxo Group Ltd | PYRAZOLOPYRIDINES | 
| DE60201074T2 (en) | 2001-03-08 | 2005-09-15 | Smithkline Beecham Corp. | pyrazolopyridine derivatives | 
| EP1372642A1 (en)* | 2001-03-30 | 2004-01-02 | SmithKline Beecham Corporation | Use of pyrazolopyridines as therapeutic compounds | 
| WO2002078700A1 (en) | 2001-03-30 | 2002-10-10 | Smithkline Beecham Corporation | Pyralopyridines, process for their preparation and use as therapteutic compounds | 
| DE60212949T2 (en) | 2001-04-10 | 2007-01-04 | Smithkline Beecham Corp. | ANTIVIRAL PYRAZOLOPYRIDINE COMPOUNDS | 
| ATE296826T1 (en) | 2001-04-27 | 2005-06-15 | Smithkline Beecham Corp | PYRAZOLO(1,5)PYRIDINE DERIVATIVES | 
| JP2005500315A (en) | 2001-06-21 | 2005-01-06 | スミスクライン ビーチャム コーポレーション | Imidazo [1,2-a] pyridine derivatives for prevention and treatment of herpes virus infection | 
| US7115617B2 (en) | 2001-08-22 | 2006-10-03 | Amgen Inc. | Amino-substituted pyrimidinyl derivatives and methods of use | 
| US6939874B2 (en) | 2001-08-22 | 2005-09-06 | Amgen Inc. | Substituted pyrimidinyl derivatives and methods of use | 
| JP2005507878A (en)* | 2001-09-07 | 2005-03-24 | スミスクライン ビーチャム コーポレーション | Pyrazolo-pyridines for the treatment of herpes infections | 
| US7244740B2 (en) | 2001-10-05 | 2007-07-17 | Smithkline Beecham Corporation | Imidazo-pyridine derivatives for use in the treatment of herpes viral infection | 
| EP1453830B1 (en) | 2001-12-11 | 2007-09-12 | SmithKline Beecham Corporation | Pyrazolo-pyridine derivatives as antiherpes agents | 
| ES2245772T3 (en) | 2002-03-07 | 2006-01-16 | Smithkline Beecham Corporation | DERIVATIVES OF PIRAZOLOPIRIMIDINA AND PIRAZOLOTRIAZINA AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | 
| JP2006504728A (en)* | 2002-10-03 | 2006-02-09 | スミスクライン ビーチャム コーポレーション | Pyrazolopyridine derivative therapeutic compounds | 
| WO2004087679A1 (en)* | 2003-04-01 | 2004-10-14 | Aponetics Ag | 2, 4, 6-trisubstituted pyrimidine derivatives useful for the treatment of neoplastic and autoimmune diseases | 
| WO2006055245A2 (en)* | 2004-11-17 | 2006-05-26 | Smithkline Beecham Corporation | Process for preparing pyrazolopyridine compounds | 
| JP5426878B2 (en)* | 2005-05-24 | 2014-02-26 | バーテックス ファーマシューティカルズ インコーポレイテッド | ATP-binding cassette transporter modulator | 
| UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds | 
| EP2536410B1 (en)* | 2010-02-18 | 2015-09-23 | Merck Sharp & Dohme Corp. | Substituted pyrimidine derivatives and their use in treating viral infections | 
| EP2402336A1 (en) | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazolopyridine compounds | 
| EP2402335A1 (en) | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazolopyridine compounds | 
| KR20140072177A (en)* | 2011-10-06 | 2014-06-12 | 바이엘 인텔렉쳐 프로퍼티 게엠베하 | Heterocyclylpyri(mi)dinylpyrazole | 
| DK2922828T3 (en) | 2012-11-21 | 2020-08-31 | Ptc Therapeutics Inc | 4,6-DIAMINO-PYRIMIDINE DERIVATIVES AS BMI-1 INHIBITORS TO TREAT CANCER | 
| BR112021002630A2 (en) | 2018-08-17 | 2021-05-11 | Ptc Therapeutics, Inc. | method to treat pancreatic cancer | 
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US46478A (en)* | 1865-02-21 | Isaac s | ||
| US3666440A (en)* | 1970-03-13 | 1972-05-30 | Mitsubishi Metal Mining Co Ltd | Method of recovering copper from slag | 
| EP0151962A3 (en)* | 1984-01-25 | 1985-10-02 | Beecham Group Plc | Pyrazolopyridine derivatives | 
| GB8404586D0 (en)* | 1984-02-22 | 1984-03-28 | Beecham Group Plc | Compounds | 
| GB8404584D0 (en)* | 1984-02-22 | 1984-03-28 | Beecham Group Plc | Compounds | 
| US5002941A (en) | 1985-12-12 | 1991-03-26 | Smithkline Beecham Corporation | Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors | 
| US4925849A (en)* | 1987-06-15 | 1990-05-15 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutically useful pyrazolopyridines | 
| US5155114A (en)* | 1989-01-23 | 1992-10-13 | Fujisawa Pharmaceutical Company, Ltd. | Method of treatment using pyrazolopyridine compound | 
| GB8901423D0 (en) | 1989-01-23 | 1989-03-15 | Fujisawa Pharmaceutical Co | Pyrazolopyridine compound and processes for preparation thereof | 
| WO1991000092A1 (en) | 1989-06-13 | 1991-01-10 | Smithkline Beecham Corporation | Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages | 
| AU622330B2 (en)* | 1989-06-23 | 1992-04-02 | Takeda Chemical Industries Ltd. | Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides | 
| KR930700104A (en) | 1990-06-12 | 1993-03-13 | 원본미기재 | Inhibition of diseases mediated by the 5-lipoxygenase and cyclooxygenase pathways | 
| GB9015764D0 (en)* | 1990-07-18 | 1990-09-05 | Fujisawa Pharmaceutical Co | Pyrazolopyridine compound and processes for preparation thereof | 
| EP0497258B1 (en) | 1991-01-29 | 2002-01-02 | Fujisawa Pharmaceutical Co., Ltd. | Use of adenosine antagonists in the prevention and treatment of pancreatitis and ulcer | 
| GB9107513D0 (en)* | 1991-04-10 | 1991-05-29 | Fujisawa Pharmaceutical Co | Pyrazolopyridine compound and processes for preparation thereof | 
| US5300478A (en)* | 1993-01-28 | 1994-04-05 | Zeneca Limited | Substituted fused pyrazolo compounds | 
| US5474995A (en) | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors | 
| US5521213A (en) | 1994-08-29 | 1996-05-28 | Merck Frosst Canada, Inc. | Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 | 
| US5552422A (en) | 1995-01-11 | 1996-09-03 | Merck Frosst Canada, Inc. | Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents | 
| AU5276696A (en) | 1995-04-04 | 1996-10-23 | Glaxo Group Limited | Imidazo{1,2-a}pyridine derivatives | 
| JPH11507669A (en) | 1995-06-12 | 1999-07-06 | ジー.ディー.サール アンド カンパニー | Treatment of inflammation and inflammation-related diseases with a combination of cyclooxygenase-2 inhibitor and leukotriene B (4) receptor antagonist | 
| US6136839A (en)* | 1995-06-12 | 2000-10-24 | G. D. Searle & Co. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor | 
| US5700816A (en)* | 1995-06-12 | 1997-12-23 | Isakson; Peter C. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor | 
| FR2757059B1 (en) | 1996-12-12 | 1999-01-29 | Rhone Poulenc Rorer Sa | NEW THERAPEUTIC APPLICATION OF PYRROLE DERIVATIVES | 
| FR2757166B1 (en)* | 1996-12-12 | 1999-01-29 | Rhone Poulenc Rorer Sa | PYRROLE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 
| CA2294057A1 (en) | 1997-06-13 | 1998-12-17 | Smithkline Beecham Corporation | Novel pyrazole and pyrazoline substituted compounds | 
| ES2203985T3 (en) | 1997-09-05 | 2004-04-16 | Glaxo Group Limited | DERIVATIVES OF 2,3-DIARIL-PIRAZOLO (1,5) PIRIDAZINE, ITS PREPARATION AND ITS USE AS INHIBITORS OF CYCLLOXYGENASE 2 (COX-2) `. | 
| AU3859999A (en) | 1998-05-14 | 1999-11-29 | G.D. Searle & Co. | 1,5-diaryl substituted pyrazoles as p38 kinase inhibitors | 
| US6245789B1 (en) | 1998-05-19 | 2001-06-12 | The Procter & Gamble Company | HIV and viral treatment | 
| FR2779724B1 (en) | 1998-06-10 | 2001-04-20 | Rhone Poulenc Rorer Sa | PYRROLE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 
| ATE275148T1 (en) | 1998-11-03 | 2004-09-15 | Glaxo Group Ltd | PYRAZOLOPYRIDINE DERIVATIVES AS SELECTIVE COX-2 INHIBITORS | 
| WO2000052008A1 (en) | 1999-02-27 | 2000-09-08 | Glaxo Group Limited | Pyrazolopyridines | 
| DE60008382T2 (en) | 1999-06-28 | 2004-12-02 | Janssen Pharmaceutica N.V. | RESPIRATORY SYNCYTIAL VIRUS REPLICATION INHIBITORS | 
| GB9919778D0 (en) | 1999-08-21 | 1999-10-27 | Zeneca Ltd | Chemical compounds | 
| PE20020506A1 (en) | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | PIRAZOLE DERIVATIVES FUSED AS PROTEIN KINASE INHIBITORS | 
| AUPQ969800A0 (en) | 2000-08-28 | 2000-09-21 | Fujisawa Pharmaceutical Co., Ltd. | Pyrazolopyridine compound and pharmaceutical use thereof | 
| AU2002239348A1 (en) | 2000-12-15 | 2002-06-24 | Glaxo Group Limited | Pyrazolopyridine derivatives | 
| ATE301653T1 (en) | 2000-12-15 | 2005-08-15 | Glaxo Group Ltd | PYRAZOLOPYRIDINES | 
| GB0103926D0 (en) | 2001-02-17 | 2001-04-04 | Astrazeneca Ab | Chemical compounds | 
| EP1372642A1 (en)* | 2001-03-30 | 2004-01-02 | SmithKline Beecham Corporation | Use of pyrazolopyridines as therapeutic compounds | 
| ATE296826T1 (en)* | 2001-04-27 | 2005-06-15 | Smithkline Beecham Corp | PYRAZOLO(1,5)PYRIDINE DERIVATIVES | 
| CA2450555A1 (en) | 2001-06-25 | 2003-01-03 | Merck & Co., Inc. | (pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds | 
| CA2509085C (en)* | 2002-12-12 | 2012-06-19 | Shell Canada Limited | Bore hole tool assembly, bearing system for use in such a bore hole tool assembly, and method of designing such a bore hole tool assembly | 
| Publication number | Publication date | 
|---|---|
| ES2243579T3 (en) | 2005-12-01 | 
| EP1377573B1 (en) | 2005-07-27 | 
| ATE300541T1 (en) | 2005-08-15 | 
| WO2002048148A2 (en) | 2002-06-20 | 
| JP2004515550A (en) | 2004-05-27 | 
| EP1377573A2 (en) | 2004-01-07 | 
| DE60112330T2 (en) | 2006-04-13 | 
| US20070287721A1 (en) | 2007-12-13 | 
| DE60112330D1 (en) | 2005-09-01 | 
| WO2002048148A3 (en) | 2003-05-01 | 
| US7163940B2 (en) | 2007-01-16 | 
| US20050049259A1 (en) | 2005-03-03 | 
| Publication | Publication Date | Title | 
|---|---|---|
| AU2002239344A1 (en) | Pyrazolopyridines | |
| AU2002239348A1 (en) | Pyrazolopyridine derivatives | |
| AU2002305143A1 (en) | Pyrazolo'1,5-a!pyridine derivatives | |
| AU2003228770A1 (en) | Substituted pyrazolopyrimidines | |
| DE602004021472D1 (en) | Pyrimiidinverbindungen | |
| PL366198A1 (en) | Novel compounds | |
| MXPA02012033A (en) | 2-aminocarbonyl-9h-purine derivatives. | |
| MY134892A (en) | Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use | |
| MXPA02012271A (en) | Novel compounds possessing antibacterial, antifungal or antitumor activity. | |
| ATE332301T1 (en) | ANTIVIRAL PYRAZOLOPYRIDINE COMPOUNDS | |
| IL158667A0 (en) | Imidazo [1,2-a] pyridine derivatives for the prophylaxis and treatment of herpes viral infections | |
| AU2001264474A1 (en) | Admantane derivatives | |
| MXPA04004498A (en) | N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation. | |
| WO2004100865A3 (en) | New benzimidazole derivatives | |
| AU2003217712A1 (en) | Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them | |
| AU2002357740A1 (en) | Pyrazolo-pyridine derivatives as antiherpes agents | |
| AU2002248531A1 (en) | Pyrazolopyriadine derivatives | |
| WO2004087652A3 (en) | Imidazotriazine compounds | |
| PT1427417E (en) | 3-substituted 6,7-dihydroxytetrahydroisoquinoline derivatives for use as antibacterial agents | |
| MXPA02012426A (en) | Novel compounds. | |
| WO2003080631A3 (en) | Plasma carboxypeptidase b inhibitors | |
| SE9904128D0 (en) | Novel compounds | |
| YU82302A (en) | 2-aminocarbonyl-9h-purine derivatives | |
| TWI231815B (en) | Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents |